Abstract
SummaryAn in vitro assay measuring AMP: and IMP: pyrophosphate phosphoribosyltransferase (EC 2.4.2.7 and EC 2.4.2.8) levels in intact leukocytes has been described. Intact erythrocytes incorporate insignificant amounts of precursor compared with leukocytes. The mean level of IMP pyrophosphate phosphoribosyltransferase in leukocytes from nine patients with acute myelogenous leukemia in relapse was significantly higher (0.01 0.001)) than in normal leukocytes. The levels of leukocyte AMP: pyrophosphate phosphoribosyltransferase were higher in leukemics but not significantly so compared with normal values. No significant reduction of IMP: pyrophosphate phosphoribosyltransferase activity was observed in leukocytes from leukemics clinically resistant to purine analogs. No correlation could be found between leukocyte enzyme activity and relapse, remission or therapy of leukemia. Enzyme levels in leukocytes isolated from patients with other malignancies were in the normal range. However, in a number of leukemic...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callMore From: Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N.Y.)
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
